April 2019 - SUSPENSION dosage pharmaceutical drug information and patent profiles

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration	Dosage
Aaipharma Llc	DARVON-N	propoxyphene napsylate	SUSPENSION;ORAL	016861-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SUSPENSION;ORAL
Abbott	PENTOTHAL	thiopental sodium	SUSPENSION;RECTAL	011679-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SUSPENSION;RECTAL
Actavis Mid Atlantic	CAPITAL AND CODEINE	acetaminophen; codeine phosphate	SUSPENSION;ORAL	085883-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SUSPENSION;ORAL
Akorn	COR-OTICIN	hydrocortisone acetate; neomycin sulfate	SUSPENSION/DROPS;OPHTHALMIC	060188-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SUSPENSION/DROPS;OPHTHALMIC
Alcon	ECONOPRED	prednisolone acetate	SUSPENSION/DROPS;OPHTHALMIC	017468-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SUSPENSION/DROPS;OPHTHALMIC
Alcon	ISOPTO CETAPRED	prednisolone acetate; sulfacetamide sodium	SUSPENSION;OPHTHALMIC	087547-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up	SUSPENSION;OPHTHALMIC
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration	Dosage